← Back to Search

Behavioral Intervention

Online Pivotal Response Treatment for Autism (PRT-O Trial)

N/A
Waitlist Available
Led By Grace Gengoux, PhD
Research Sponsored by Stanford University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
2:0 to 5:11 years at the time of consent
Diagnosed with ASD or suspicion of Autism Spectrum Disorder diagnosis, confirmed with ADI-R
Must not have
Previous adequate trial of pivotal response treatment resulting in parent meeting Pivotal Response Treatment fidelity of implementation at baseline
Receiving more than 15 hours of in-home 1:1 ABA per week
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 weeks and 12 weeks
Awards & highlights

Summary

This trial will look at how well a training course called Pivotal Response Treatment Online (PRT-O) helps parents of children with Autism Spectrum Disorder (ASD) learn to deliver PRT effectively

Who is the study for?
This trial is for parents of children with Autism Spectrum Disorder (ASD). It aims to teach them how to deliver Pivotal Response Treatment (PRT) through an online course. Specific eligibility criteria are not provided, but typically participants would need reliable internet access and a commitment to complete the training.
What is being tested?
The study is testing the effectiveness of an Online Pivotal Response Treatment Training Course (PRT-O) designed for parents. The goal is to see if parents can learn and apply PRT methods effectively with their ASD-diagnosed children after taking this online course.
What are the potential side effects?
Since this intervention involves educational material rather than medication or medical procedures, traditional side effects are not applicable. However, participants may experience stress or frustration associated with learning new techniques and applying them in a home setting.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am between 2 and 5 years old.
Select...
I have been diagnosed with ASD or suspected to have it, confirmed by ADI-R.
Select...
I have major difficulties in communicating effectively.
Select...
I am an English-speaking parent who can participate in and follow treatment in English.
Select...
I receive 60 minutes or less of speech therapy weekly.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I have completed a pivotal response treatment program successfully.
Select...
I am getting over 15 hours of one-on-one ABA therapy at home weekly.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 weeks and 12 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 weeks and 12 weeks for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change from Baseline on Child Functional Verbal Utterances as measures on the Home Video Observation (HVO)
Change from Baseline on Parent Fidelity of Pivotal Response Treatment Implementation as measured on the Home Video Observation (HVO)

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Pivotal Response Treatment Online (PRT-O) CourseExperimental Treatment1 Intervention
The PRT-O Online Course (PRT-O) will consist of 10 online lessons completed asynchronously through the Stanford LearnMed Online CANVAS Platform. Parents are expected to view the 10 lessons over the course of a 12-week study period, complete worksheets, and to practice PRT at home.
Group II: Delayed Treatment Group (DTG)Active Control1 Intervention
No intervention.

Find a Location

Who is running the clinical trial?

Stanford UniversityLead Sponsor
2,448 Previous Clinical Trials
17,492,350 Total Patients Enrolled
35 Trials studying Autism Spectrum Disorder
4,082 Patients Enrolled for Autism Spectrum Disorder
Grace Gengoux, PhDPrincipal InvestigatorStanford University
1 Previous Clinical Trials
44 Total Patients Enrolled
1 Trials studying Autism Spectrum Disorder
44 Patients Enrolled for Autism Spectrum Disorder
~29 spots leftby Dec 2027